Cite
HARVARD Citation
Smolen, J. et al. (n.d.). FRI0164 Predictors of loss of clinical remission with etanercept 50 mg, 25 mg or placebo combined with methotrexate in moderate rheumatoid arthritis patients: Results of the preserve trial. Annals of the rheumatic diseases. p. 367. [Online].